Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Neoplasms 518Breast Neoplasms 454Lung Neoplasms 252Prostatic Neoplasms 234Colorectal Neoplasms 216Carcinoma, Non-Small-Cell Lung 185Pancreatic Neoplasms 154Carcinoma, Hepatocellular 136Stomach Neoplasms 134Ovarian Neoplasms 116Multiple Myeloma 98Melanoma 93Head and Neck Neoplasms 92Esophageal Neoplasms 90Disease 87Urinary Bladder Neoplasms 85Uterine Cervical Neoplasms 78Lymphoma 78Brain Neoplasms 75Liver Neoplasms 74Hematologic Neoplasms 74Endometrial Neoplasms 71Leukemia, Myeloid, Acute 66Neoplasm Metastasis 65Colonic Neoplasms 61Rectal Neoplasms 59Precursor Cell Lymphoblastic Leukemia-Lymphoma 56Glioma 54Sarcoma 53Leukemia 53

Interventions

Exome 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Observational × Lung Squamous Cell Carcinoma × Clear all
NCT05778253 2023-03-21

The Role of ctDNA Testing Plus AI-based Pathology in Resectable LSCC

Second Xiangya Hospital of Central South University

Recruiting
50 enrolled

Lung Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡